71.86 USD
↘ 2.00 (2.78%)PRE MARKET (AS OF 04:09 AM EDT)
Spyre Therapeutics, Inc. Common Stock
SYRENASDAQ • USD
Market: OPEN
Open?$71.45
High?$71.45
Low?$69.90
Prev. Close?$71.90
Volume?707
Avg. Volume?1.2M
VWAP?$70.17
Rel. Volume?0.00x
Bid / Ask
Bid?$61.74 × 100
Ask?$81.14 × 100
Spread?$19.40
Midpoint?$71.44
Valuation & Ratios
Market Cap?6.2B
Shares Out?78.8M
Float?66.9M
Float %?85.2%
P/E Ratio?N/A
P/B Ratio?8.67
EPS?-$1.47
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?13.25Strong
Quick Ratio?13.25Strong
Cash Ratio?1.46Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?8.67HIGH▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-27.9CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-17.7%WEAK▾
ROA?-16.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$6.1B
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
Address
221 CRESCENT STREET
WALTHAM, MA 02453
Phone: (617) 651-5940
WALTHAM, MA 02453
Phone: (617) 651-5940